Leo Pharma goes head to head with Janssen in new psoriasis trial
Leo Pharma will test its psoriasis drug Kyntheum against Janssen's Tremfya, thereby also testing new-generation biologic treatments for psoriasis.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
In a new clinical trial, Danish pharmaceutical company Leo Pharma tries to get wind in the sails of the firm's first biologic treatment, Kyntheum.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
